Exagen | 10-K: Annual report
Exagen | 8-K: Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer ABALLI JOHN
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer ABALLI JOHN
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(6.8%)
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Stonepine Capital Management, LLC(3.9%),Stonepine Capital, L.P(3.9%), etc.
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James L.L. Tullis(10.7%),Tullis-Dickerson Capital Focus III, L.P.(6.5%), etc.
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Exagen | 4: Statement of changes in beneficial ownership of securities-Officer Adawi Kamal
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cowen Financial Products LLC(5.27%)
Exagen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-NMSIC Co-Investment Fund, L.P.(13.55%),Sun Mountain Capital Partners, L.L.C.(13.55%)
Exagen | 8-K: Current report
Exagen | 8-K: Current report
Exagen | EFFECT: Others
Exagen | 424B5: Prospectus
Exagen | CORRESP: CORRESP
Exagen | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
No Data